Selecting a pharmacotherapy regimen for patients with chronic insomnia
Open Access
- 23 March 2020
- journal article
- other
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 21 (9) , 1035-1043
Abstract
Chronic insomnia, whether it is primary or in combination with another medical or psychiatric disorder, is a prevalent condition associated with significant morbidity, reduced productivity, increas...Keywords
Funding Information
- U.S. Department of Veterans Affairs (CX 001656)
This publication has 107 references indexed in Scilit:
- Risk of Dementia in Patients with Insomnia and Long-term Use of Hypnotics: A Population-based Retrospective Cohort StudyPLOS ONE, 2012
- A Randomized, Placebo-Controlled Trial of Online Cognitive Behavioral Therapy for Chronic Insomnia Disorder Delivered via an Automated Media-Rich Web ApplicationSLEEP, 2012
- Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic reviewBMC Family Practice, 2012
- Benzodiazepine Use Possibly Increases Cancer RiskThe Journal of Clinical Psychiatry, 2012
- Hypnotics' association with mortality or cancer: a matched cohort studyBMJ Open, 2012
- Next-Day Effects of Ramelteon (8 mg), Zopiclone (7.5 mg), and Placebo on Highway Driving Performance, Memory Functioning, Psychomotor Performance, and Mood in Healthy Adult SubjectsSLEEP, 2011
- Insomnia and the Performance of US Workers: Results from the America Insomnia SurveySLEEP, 2011
- Grand challenges in global mental healthNature, 2011
- Efficacy of Brief Behavioral Treatment for Chronic Insomnia in Older AdultsArchives of internal medicine (1960), 2011
- Clinical evaluation of zaleplon in the treatment of insomniaNature and Science of Sleep, 2010